Effect of Consumption of Supplements and Enriched Olive Paste on Bone Metabolism Indices
Conditions: Osteopenia or Osteoporosis Interventions: Other: Functional olive paste; Other: Calciovitmag (CDCaMg); Other: Phosporovitmag (PDCaMg); Other: Control Sponsors: University of the Aegean Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Preserving Geriatric Muscle With an Osteoporosis Medication
Conditions: Osteoporosis Interventions: Drug: Denosumab 60 MG/ML; Drug: Zoledronic Acid 5Mg/Bag 100Ml Infusion Sponsors: Susan L. Greenspan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Opportunistic Fragility Fracture Risk Estimates From Radiographs
Conditions: Osteoporosis Interventions: Device: IbexBH Software Sponsors: University of Exeter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects.
Conditions: Hydrogen Sulfide; Osteoporosis Interventions: Other: inhalatory treatment with sulfureous aerosol Sponsors: Istituto Ortopedico Rizzoli Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Investigation of the Effects of Physical Activity in Women at Risk of Osteoporosis
Conditions: Osteoporosis Risk Interventions: Other: Exercise Sponsors: Pamukkale University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
A Study of Romosozumab (EVENITY ®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.
Conditions: Postmenopausal Osteoporosis Interventions: Drug: Romosozumab Sponsors: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
The Living With a Long-Term Condition Study
Conditions: Asthma; Atrial Fibrillation; Cancer; Cerebrovascular Disorders; Stroke; CKD; Copd; Fibromyalgia; Pain; Heart Diseases; Heart Disease Chronic; Dementia; Diabetes; Epilepsy; Heart Failure; High Blood Pressure; Hypertension; Hiv; AIDS; IBD; IBS; Liver Diseases; Long COVID; Lupus Erythematosus; Multiple Sclerosis; Obesity; Osteoarthritis; Arthritis; Rheumatoid Arthritis; Osteoporosis; Parkinson Disease; Sickle Cell Disease; Hepatitis; Endometriosis; PCOS; Neurological Disorder; POTS - Postural Orthostatic Tachycardia Syndrome; MND (Motor Neurone DIsease); Cystic Fibrosis; Migraine; Spondylitis; Celiac Disease; Hidr...
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
National Registry of Rare Kidney Diseases
Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Den...
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
The Optimised Use of Romozosumab Study
Condition: Osteoporosis Interventions: Drug: Romosozumab; Drug: Zoledronate Sponsor: University of Aarhus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
The Optimised Use of Romozosumab Study
Conditions: Osteoporosis Interventions: Drug: Romosozumab; Drug: Zoledronate; Drug: Romosozumab; Drug: Zoledronate; Drug: Romosozumab; Drug: Zoledronate Sponsors: University of Aarhus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Condition: Osteoporosis Interventions: Drug: Donepezil; Drug: Placebo Sponsors: Duke University; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
